in , ,

Tom Cruise Feels Betrayed by Hollywood Despite “Saving its A**”, Reportedly Unhappy for Christopher Nolan’s Oppenheimer Getting Majority IMAX Theaters

Tom Cruise Feels Betrayed by Hollywood Despite "Saving its A**", Reportedly Unhappy for Christopher Nolan's Oppenheimer Getting Majority IMAX Theaters

Tom Cruise seems to be on the back foot in Hollywood right now as his upcoming movie is bound to collide with Christopher Nolan’s magnum opus Oppenheimer. With reservations for IMAX seats, it seems that Cruise wants the premium theaters for Mission: Impossible – Dead Reckoning Part One instead of the atomic bomb movie.

As per speculated reports, the actor-producer has been trying to strike up deals with insiders to get the IMAX theater privileges and remove Nolan’s Oppenheimer from the premium screens. Although it has not been confirmed, there are conflicting reports and backstabbing from both sides to hear of!

Tom Cruise
Tom Cruise

Tom Cruise Will Not Get IMAX Theaters Despite Saving Hollywood

The actor was recently praised for essentially “saving Hollywood’s a**” by starring in Top Gun: Maverick back in May 2022. The film was so well received by the audience that it created a buzz for the theater experience once again after quite a long time.

Fandomwire Video
Christopher Nolan while directing Oppenheimer
Christopher Nolan while directing Oppenheimer

Also read: Avengers: Endgame Star Had to Constantly Send Her Fighting Videos to Get a Role in Tom Cruise’s $300 Million Action Movie ‘Mission Impossible 7’

With the upcoming magnum opus Oppenheimer entirely shot in IMAX format, Christopher Nolan has already had a deal that his movie will be shown in all the IMAX theaters across North America for three weeks. Things would not be as simple in Hollywood as they look since Tom Cruise’s Mission: Impossible – Dead Reckoning Part One is releasing exactly 10 days prior to the launch of Oppenheimer.

As per reports by Puck, the Top Gun actor also wants the IMAX theaters for his movie and wants to challenge Nolan with his movie. In the speculated reports, it is stated that Tom Cruise allegedly called rival studios to get his movie in the Premium Large Format (PLF) available for a longer time so that Oppenheimer may get a shorter duration of the IMAX theaters.

With Tom Cruise in efforts to pursue the PLFs, a representative of IMAX revealed to IndieWire that they aim to remain loyal to Christopher Nolan.

Suggested: WB Shows Middle Finger to Christopher Nolan After Betrayal, Deliberately Clashes Barbie With Cillian Murphy’s Oppenheimer to Humiliate Director

Tom Cruise’s Efforts May Not Bear Fruit This Time!

Tom Cruise in Mission: Imposibble - Dead Reckoning Part One.
Tom Cruise in Mission: Impossible – Dead Reckoning Part One.

Related: Tom Cruise “Nabbed” $273,600,000 Movie Role from Hugh Grant, Who Now Regrets Rejecting it: “It very nearly utterly killed my career”

With Nolan’s deal already done with IMAX, the director’s plan is to release Oppenheimer in all the IMAX theaters across North America for three weeks after its release. With Tom Cruise pursuing the PLFs aggressively, an IMAX representative apparently had a chat with IndieWire.

As per the reports, the representative stated that they are fully committed to the Oppenheimer plan. With 1550 IMAX theaters at the ready and a total of 1700 venues, it seems that Tom Cruise’s efforts might not be worth it this time. Tom Cruise’s Mission: Impossible – Dead Reckoning Part One is set for a release date of 12th July 2023 while Christopher Nolan’s Oppenheimer is slated for a release date of 21st July 2023 in theaters across the U.S.

Source: IndieWire

Written by Visarg Acharya

Visarg Acharya joined FandomWire in 2022 as a Content Writer. Along with a penchant for writing, Visarg claims that words are the only true language made for him. Currently pursuing his B.Sc in Physics, the combination of Physics and Marvel make up for an interesting talk. Visarg Acharya has authored over 500 articles and reads books in his spare time along with an occasional series to accompany him.